Spanish Biotech Votum Labs Raises 1.2 Million Euros in Pre-Series A Round

✦ Meridian Analysis

Votum Labs, a Spanish biotechnology firm, has closed a €1.2 million pre‑Series A equity round backed by the family office of the Region of Murcia. The company is now valued at over €10 million. The family office provides capital that the biotech will use for international expansion and commercial development. The mechanics are those of a private placement of equity in an early‑stage round, with no debt component or syndicated financing involved, and the deal is reported as closed without any disclosed pricing, multiple or advisory arrangements. Going forward, participants will be watching for the terms of the next financing tranche, any strategic partnerships that may accompany commercial rollout, and the timeline for regulatory clearances on Votum’s pipeline. The announcement did not disclose the share price, the exact equity stake taken by the family office, the identity of any financial advisers, or the conditions precedent to the funding, all of which are typical points of interest for deal professionals.

The Meridian Weekly